Evaluation of In-Vivo Antidiabetic and Antihyperlipidemic Potential of Bismarckia nobilis Extract

India has one of the world's highest diabetes burdens. As of 2024, an estimated 89.8 million individuals (20-79 years old) in India have diabetes, with the figure expected to climb to 156.7 million by 2050. Diabetes prevalence is influenced by urbanization, lifestyle changes, and rising obesity rates. Diabetes and high lipid levels are two closely associated diseases, with raised cholesterol levels being a typical side effect of diabetes. The aerial part of Bismarckia nobilis was dried using an electric blender, powder was macerated in petroleum ether, solid form was left to stand for 3-7 days, filtered, dried, and then macerated with ethanol and hot water to complete extraction. The hydroalcoholic extract of bismarckia nobilis (HEBN) was administered at dosages of 200 mg/kg and 400 mg/kg to normoglycemic Wistar rats, as well as a single and repeated dose to streptozotocin-induced diabetes models. Blood glucose levels were assessed in the normoglycemic, oral glucose-loaded, and single-dose streptozotocin models. Blood glucose levels, body weight, and lipid profiles were assessed in the diabetic animal treated with repeated doses. The abnormally high concentration of serum lipids in the diabetic condition is mainly due to an increase in the mobilization of free fatty acids from the peripheral fat depots, since insulin inhibits the hormone-sensitive lipase. In the present study, the blood sample was withdrawn on the 28th day, and it was found that 200 mg/kg was not effective for lowering the LDL level in diabetic-induced rats, but 400 mg/kg had a significant decrease in LDL levels. Both extracts (HEBN 200 and HEBN 400 mg/kg) showed a highly significant effect on triglyceride levels in the iii to v group. The study shows that Bismarckia nobilis extracts, especially at 400 mg/kg, may help control high blood sugar and improve fat levels in diabetics. More research is needed to understand its effects and to ensure safety. If successful, Bismarckia nobilis could enhance diabetes treatments and provide extra health benefits. These extracts might be a good option for new herbal medicines for diabetes and lipid issues.